AASLD/ILTS Transplant Course: Liver Transplantation – State of the Science 

|

Leading clinicians from around the world will present the most recent clinical and scientific advances affecting the field of liver transplantation. They will focus on three areas:

• Management advances in hepatobiliary malignancies, particularly hepatocellular carcinoma and cholangiocarcinoma
  
  
• Infectious and donor transmitted diseases, including developments in hepatitis B and C, and donor transmission of West Nile and H1N1
  
  
• Emerging issues, including advances in immunosuppression and approaches to pre- and post-transplant metabolic complications and renal insufficiency

Goals and Objectives:

• Describe how recent knowledge from clinical investigation can be translated into optimal approaches to the management of hepatobiliary malignancies before and after liver transplantation
  
  
• Explain how to apply new developments in the strategies for the treatment of hepatitis B and C to the transplant arena
  
  
• Discuss the impact of, and management for, donor-transmitted infectious diseases
  
  
• Explain the implications of advances in allocation strategies for high-risk donor organs, immunosuppression, and approaches to pre- and post-transplant metabolic complications and renal insufficiency